Cue Biopharma
80 hedge funds and large institutions have $39.7M invested in Cue Biopharma in 2023 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 25 increasing their positions, 20 reducing their positions, and 6 closing their positions.
Holders
80
Holders Change
+5
Holders Change %
+6.67%
% of All Funds
1.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
25
Reduced
20
Closed
6
Calls
$769K
Puts
$105K
Net Calls
+$664K
Net Calls Change
+$522K
Top Buyers
| 1 |
BL
1
Bleichroeder LP
New York
|
$4.63M |
| 2 |
2
BlackRock
New York
|
$6.17M |
| 3 |
3
Morgan Stanley
New York
|
$870K |
| 4 |
4
Bank of America
Charlotte,
North Carolina
|
$703K |
| 5 |
5
Jane Street
New York
|
$144K |
